COVID-19January 12, 2021
Perspectives on Use of the COVID-19 Vaccines and Psoriatic Disease
Claim CME Credits & View Disclosures
A discussion with NPF COVID-19 Task Force co-chairs dermatologist Dr. Joel Gelfand and rheumatologist Dr. Christopher Ritchlin with guest host Dr. Stacie Bell Chief Scientific and Medical Officer at the National Psoriasis Foundation.
COVID-19 Task Force co-chairs dermatologist Dr. Joel Gelfand, Psoriasis & Phototherapy Treatment Center at Penn, and rheumatologist Dr. Christopher Ritchlin, Psoriasis Center, University of Rochester Medical Center, return to discuss the new vaccines and their use with psoriatic disease treatments.
This program is supported by educational grants from Lilly, Bristol Myers Squibb and Novartis.